Cargando…
Clinical effectiveness and safety of low cost versus innovator brand amlodipine in hypertension: A single-blinded, randomized, crossover, noninferiority trial
OBJECTIVES: A single-blinded, randomized, crossover, noninferiority trial was conducted to evaluate clinical effectiveness and safety of low-cost brand (LCB) versus innovator brand (IB) amlodipine in essential hypertension. MATERIALS AND METHODS: The primary end-point was change of systolic blood pr...
Autores principales: | Das, Alak Kumar, Chatterjee, Suparna, Pal, Jyotirmoy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5155474/ https://www.ncbi.nlm.nih.gov/pubmed/28066111 http://dx.doi.org/10.4103/0253-7613.194844 |
Ejemplares similares
-
Comparative efficacy of generic nifedipine versus brand‐name amlodipine for hypertension management in Taiwan
por: Lee, Hao‐Wei, et al.
Publicado: (2022) -
Hemorheological effects of amlodipine in spontaneously hypertensive rats
por: Shamanaev, Aleksandr Y., et al.
Publicado: (2017) -
Comparative Learning Curves of Microscope Versus Exoscope: A Preclinical Randomized Crossover Noninferiority Study
por: Layard Horsfall, Hugo, et al.
Publicado: (2022) -
Reporting of Differences in Taste Between Branded and Unbranded Cigarettes by Smokers Blinded to Cigarette Branding: Within-Person, Randomized Crossover Study
por: BinDhim, Nasser F, et al.
Publicado: (2021) -
Amlodipine and cardiovascular outcomes in hypertensive patients: meta-analysis comparing amlodipine-based versus other antihypertensive therapy
por: Lee, Seung-Ah, et al.
Publicado: (2014)